94 related articles for article (PubMed ID: 23048192)
21. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
22. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
[TBL] [Abstract][Full Text] [Related]
23. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
Soveri I; Holdaas H; Jardine A; Gimpelewicz C; Staffler B; Fellström B
Nephrol Dial Transplant; 2006 Aug; 21(8):2282-9. PubMed ID: 16574686
[TBL] [Abstract][Full Text] [Related]
24. Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.
Perticone F; Sciacqua A; Maio R; Perticone M; Laino I; Bruni R; Cello SD; Leone GG; Greco L; Andreozzi F; Sesti G
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):481-6. PubMed ID: 19531955
[TBL] [Abstract][Full Text] [Related]
25. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK;
J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679
[TBL] [Abstract][Full Text] [Related]
26. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
[TBL] [Abstract][Full Text] [Related]
27. Platelet function and spontaneous thrombolytic activity of patients with cerebral infarction assessed by the global thrombosis test.
Taomoto K; Ohnishi H; Kuga Y; Nakashima K; Ichioka T; Kodama Y; Kubota H; Tominaga T; Hirose T; Hayashi M; Kinugasa C; Yamashita T; Yamamoto J
Pathophysiol Haemost Thromb; 2010; 37(1):43-8. PubMed ID: 20516672
[TBL] [Abstract][Full Text] [Related]
28. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
29. Psoriasis and Cardiovascular Disease: epidemiological studies.
Ahlehoff O
Dan Med Bull; 2011 Nov; 58(11):B4347. PubMed ID: 22047936
[TBL] [Abstract][Full Text] [Related]
30. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
[TBL] [Abstract][Full Text] [Related]
31. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
Adragao T; Pires A; Lucas C; Birne R; Magalhaes L; Gonçalves M; Negrao AP
Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
[TBL] [Abstract][Full Text] [Related]
32. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.
Taal MW; Sigrist MK; Fakis A; Fluck RJ; McIntyre CW
Nephron Clin Pract; 2007; 107(4):c177-81. PubMed ID: 17975325
[TBL] [Abstract][Full Text] [Related]
33. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
Diepeveen SH; Verhoeven GH; van der Palen J; Dikkeschei BL; van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
Nephron Clin Pract; 2004; 98(1):c3-7. PubMed ID: 15361698
[TBL] [Abstract][Full Text] [Related]
35. Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy.
Péquériaux NC; Fijnheer R; Gemen EF; Barendrecht AD; Dekker FW; Krediet RT; Beutler JJ; Boeschoten EW; Roest M
Nephrol Dial Transplant; 2012 Jun; 27(6):2452-7. PubMed ID: 22189209
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses.
Mimura I; Nishi H; Mise N; Mori M; Sugimoto T
Nephrology (Carlton); 2010 Aug; 15(5):549-54. PubMed ID: 20649875
[TBL] [Abstract][Full Text] [Related]
37. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
38. [Cardiovascular events in patients with chronic kidney disease].
Meng L; Ding WH; Shi LB; Jiang J; Liu ZP; Gong YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):53-5. PubMed ID: 19671354
[TBL] [Abstract][Full Text] [Related]
39. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.
Postorino M; Marino C; Tripepi G; Zoccali C;
J Am Coll Cardiol; 2009 Apr; 53(15):1265-72. PubMed ID: 19358939
[TBL] [Abstract][Full Text] [Related]
40. Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study).
Lindberg S; Mogelvang R; Pedersen SH; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
Am J Cardiol; 2013 Apr; 111(8):1139-45. PubMed ID: 23375598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]